1-7
China's xFusion taps Citic Securities for IPO preparation after 2024 AI server boom
Chinese AI server maker xFusion has appointed Citic Securities as its investment bank and begun formal IPO preparation following strong 2024 revenue of over 40 billion yuan. The IPO tutoring phase is slated to run from early January through as late as April or May 2026, as the company moves to join a wave of Chinese AI and chip firms listing in Shanghai and Hong Kong amid intensified state backing for domestic technology.
1-7
1-6
DeepSeek faces heightened global regulatory pressure over data privacy and security
On January 6 2026, regulators across multiple countries were reported to be intensifying scrutiny of Chinese AI startup DeepSeek over data security, privacy compliance and national security risks. Authorities in Australia, the Czech Republic, France, Germany, India, South Korea, Italy, the Netherlands and Taiwan have launched bans, restrictions or investigations, while US officials are weighing export curbs, military blacklisting and further probes into chip access and data practices.
1-6
1-6
DGrid Launches Decentralized AI Infrastructure And Premium NFT Membership On January 1, 2026
DGrid introduces a decentralized AI infrastructure that uses a tokenized, DAO-governed network to deliver verifiable, low‑cost inference across Web3. The project combines a Proof of Quality mechanism, modular architecture, and a premium membership NFT that offers lifetime access to aggregated AI services and allocates 50% of total $DGAI supply to NFT holders. Sales of the DGrid Premium NFT began on January 1, 2026, framing participation as both access to AI tools and exposure to the ecosystem's future growth.
DAO
DAO+0.04%
1-6
1-6
Climate tech investors eye AI energy, grid in 2026; nuclear deal hits $6B
Investment managers focused on climate technology plan to lift allocations in 2026 as financing costs ease and regulatory guidance firms up, while emphasizing profitability. AI-driven power demand and grid upgrades stand out, with US grid spending at $115 billion in 2025 and projected above $128 billion within two years. Nuclear draws mixed views despite a more than $6 billion fusion tie-up announced in December; alternative proteins face steep funding declines.
1-6